Primary Care Optometry News

CURRENTLY VIEWING:

The following articles appeared in the print edition of PRIMARY CARE OPTOMETRY NEWS.

Table of Contents

Alcon ends UPP after Utah law is upheld

LensFerry S expands to all modalities

Most adults do not discuss digital device usage with ODs

American Optometric Student Association elects new board

Paragon CRT lenses approved by China FDA

CooperVision launches Avaira Vitality toric

B+L expands range for Ultra for presbyopia

Essilor, Luxottica to merge

Bausch + Lomb introduces scleral contacts

Expert outlines low vision devices for primary care ODs

Positive phase 3 results for Sun’s dry eye agent

SynergEyes, Menicon partner to expand specialty lens portfolio

X-Cel adds Atlantis scleral designs

From The Editor

Time-release delivery is the future of allergy management

Michael D. DePaolis, OD, FAAO

In the Journals

Diplopia frequently found in treated glaucoma patients

Efficacy of antioxidants for oxidative stress may depend on age

iStent implantation during cataract surgery reduces IOP in Hispanic cohort

Survey: Referral rate for low vision services low among glaucoma specialists

iStent implantation during cataract surgery reduces IOP in Hispanic cohort

Povidone-iodine promising for bacterial keratitis in developing world

Medicare Coding

Review your own records to avoid Medicare paybacks

Charles B. Brownlow, OD

Meeting News

Mah gives immunogenic herpes treatment update

OCT angiography offers dual advantage of imaging structure, blood flow

Lifestyle changes can help lower IOP in glaucoma patients

Maintain high level of suspicion for syphilis in young men presenting with uveitis

Predictability of glaucomatous progression uncertain

Prompt identification of corneal edema after cataract surgery needed for quick recovery

PRK with crosslinking beneficial for keratoconus patients

Study questions link between glaucoma, Alzheimer's disease

Contact lens wear has no effect on LASIK evaluation

Speaker: Hang on for the ride in health care

Lampalizumab is first therapeutic to show efficacy in phase 2 trial for geographic atrophy

In high-risk AMD patients, challenge use of anticoagulants

PCON Reports

Future ocular allergy drug delivery methods may eliminate compliance issues

What's Your Diagnosis?

Patient complains of distorted vision

Daniel Brigham, OD

Advertisement
Advertisement